Rizalyn Golnar

Rizalyn Golnar possesses a robust background in clinical operations, with experience spanning multiple leadership roles across prominent biotech companies. At Kriya Therapeutics, Inc., Rizalyn served as Senior Vice President and previously as Vice President of Clinical Operations from June 2022 to April 2025. Prior to this, Rizalyn held the position of Senior Director and Head of Trial Operations at Xenon Pharmaceuticals Inc. from May 2021 to June 2022. Further experience includes serving as Senior Director and Director of Clinical Operations at Axovant Gene Therapies from October 2016 to May 2020, along with a role as Director of Global Clinical Operations at IMMUNE Pharmaceuticals Inc. from February 2016 to October 2016.